Literature DB >> 30944081

Hsa_circ_0001742 promotes tongue squamous cell carcinoma progression via modulating miR-634 expression.

Beibei Shao1, Longlong He2.   

Abstract

Recent studies indicated that circular RNAs (circRNAs) could play critical roles in the initiation and development of tumors, including tongue squamous cell carcinoma (TSCC). We aimed to investigate the roles and underlying mechanisms of hsa_circ_0001742 in TSCC. In the present study, results reported that the expression of hsa_circ_0001742 was obviously increased and correlated with TSCC patients with advanced clinical stage, lymph-node metastasis. In vitro function assays revealed that hsa_circ_0001742 inhibition decreased the proliferation, invasion, and epithelial-mesenchymal transition (EMT) processes of TSCC cells. Molecular mechanism demonstrated that hsa_circ_0001742 could directly bind to miR-634, which mediated the functions of hsa_circ_0001742 in TSCC tumorigenesis. Furthermore, RAB1A was a target of miR-634 and hsa_circ_0001742 modulated the expression of RAB1A through competitively binding to miR-634. Thus, our study showed that hsa_circ_0001742 could promote TSCC progression by targeting miR-634/RAB1A pathway.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Hsa_circ_0001742; RAB1A; Tongue squamous cell carcinoma; miR-634

Year:  2019        PMID: 30944081     DOI: 10.1016/j.bbrc.2019.03.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634.

Authors:  Chao Pan; Zhijian Su; Honghui Xie; Yanyang Ning; Shuangjing Li; Haibo Xiao
Journal:  Odontology       Date:  2022-10-01       Impact factor: 2.885

2.  Circ-SAR1A Promotes Renal Cell Carcinoma Progression Through miR-382/YBX1 Axis.

Authors:  Xiaolei Zhao; Zhenhua Zhao; Wenchao Xu; Hui Liu; Junkai Chang; Weibo Xu; Song Li; Songqiang Cao; Junqing Hou
Journal:  Cancer Manag Res       Date:  2020-08-18       Impact factor: 3.989

Review 3.  Functional and Clinical Impact of CircRNAs in Oral Cancer.

Authors:  Ion Cristóbal; Cristina Caramés; Jaime Rubio; Marta Sanz-Alvarez; Melani Luque; Juan Madoz-Gúrpide; Federico Rojo; Jesús García-Foncillas
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

4.  Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis.

Authors:  Cuijuan Qian; Shihang Chen; Sen Li; Yichao Wang; Jun Yao
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

5.  Hsa_circ_0002162 has a critical role in malignant progression of tongue squamous cell carcinoma through targeting miR-33a-5p.

Authors:  Chunguang Zhang; Yuan Yao; Lei Bi
Journal:  Braz J Med Biol Res       Date:  2021-03-15       Impact factor: 2.590

Review 6.  Insights Into the Involvement of Circular RNAs in Autoimmune Diseases.

Authors:  Xingyu Zhai; Yunfei Zhang; Shuyu Xin; Pengfei Cao; Jianhong Lu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis.

Authors:  Xianyun Xu; Qiongjun Xie; Mingfeng Xie; Yong Zeng; Qian Liu
Journal:  Cancer Manag Res       Date:  2021-04-07       Impact factor: 3.989

8.  Circular RNA_0001742 has potential to predict advanced tumor stage and poor survival profiles in tongue squamous cell carcinoma management.

Authors:  Yuan Yao; Lei Bi; Chunguang Zhang
Journal:  J Clin Lab Anal       Date:  2020-05-28       Impact factor: 2.352

9.  Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis.

Authors:  Minghui Zhou; Puwen Zhang; Yulin Zhao; Rui Liu; Yujie Zhang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  Hsa_circ_0043265 Restrains Cell Proliferation, Migration and Invasion of Tongue Squamous Cell Carcinoma via Targeting the miR-1243/SALL1 Axis.

Authors:  Cuijuan Qian; Yisheng Yang; Tianchen Lan; Yichao Wang; Jun Yao
Journal:  Pathol Oncol Res       Date:  2021-02-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.